A population based study of the epidemiology of Herpes Zoster and its complications

Journal of Infection

Volumn 67, Issue 5, 2013, Pages 463-469

  Weitzman, Dahlia ^a   Shavit, Oren ^b   Stein, Michal ^b   Cohen, Raanan ^b   Chodick, Gabriel ^a,c   Shalev, Varda ^a,c  

^a MACCABI HEALTHCARE SERVICES   (Israel)

^b MSD Israel Co Ltd   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Herpes Zoster; Incidence; Neuralgia; Postherpetic; Risk factors

Indexed keywords

ADULT; AGED; ARTICLE; DIABETES MELLITUS; DISEASE ASSOCIATION; ENCEPHALITIS; ETHNIC GROUP; EXTERNAL OTITIS; EYE DISEASE; FEMALE; HEMIPARESIS; HEPATITIS; HERPES ZOSTER; HIGH RISK POPULATION; HUMAN; IMMUNOCOMPROMISED PATIENT; ISRAELI; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORBIDITY; MYELITIS; NEOPLASM; NERVE PARALYSIS; PNEUMONIA; POPULATION RESEARCH; POSTHERPETIC NEURALGIA; RETROSPECTIVE STUDY; RISK FACTOR; SOCIAL STATUS;

HERPES ZOSTER; INCIDENCE; NEURALGIA; POSTHERPETIC; RISK FACTORS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HERPES ZOSTER; HUMANS; INCIDENCE; INFANT; ISRAEL; MALE; MIDDLE AGED; NEURALGIA, POSTHERPETIC; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84884701197     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2013.06.016     Document Type: Article

References (34)

1. Brisson M., Edmunds W.J., Law B., Gay N.J., Walld R., Brownell M., et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect 2001 Oct, 127(2):305-314.
2. Chapman R.S., Cross K.W., Fleming D.M. The incidence of shingles and its implications for vaccination policy. Vaccine 2003 Jun 2, 21(19-20):2541-2547.
3. Johnson R.W., Bouhassira D., Kassianos G., Leplege A., Schmader K.E., Weinke T. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med 2010, 8:37.
4. Opstelten W., Mauritz J.W., de Wit N.J., van Wijck A.J., Stalman W.A., van Essen G.A. Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam Pract 2002 Oct, 19(5):471-475.
5. Yawn B.P., Saddier P., Wollan P.C., St Sauver J.L., Kurland M.J., Sy L.S. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007 Nov, 82(11):1341-1349.
6. Gauthier A., Breuer J., Carrington D., Martin M., Remy V. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect 2009 Jan, 137(1):38-47.
7. Gialloreti L.E., Merito M., Pezzotti P., Naldi L., Gatti A., Beillat M., et al. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. BMC Infect Dis 2010, 10:230.
8. Oxman M.N., Levin M.J., Johnson G.R., Schmader K.E., Straus S.E., Gelb L.D., et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005 Jun 2, 352(22):2271-2284.
9. Harpaz R., Ortega-Sanchez I.R., Seward J.F. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008 Jun 6, 57(RR-5):1-30. [quiz CE2-4].
10. Israeli A. Health ministry director-general circular no. 21/08: expansion of health services basket for 2009 2010, Israeli Ministry of Health, Jerusalem.
11. Chai-Am E. Health ministry director-general circular no. 02/10: expansion of health services basket for 2010 2010, Israeli Ministry of Health, Jerusalem.
12. Bendelac J. Membership in sick funds 2010 2011, National Insurance Institute, Jerusalem.
13. Heymann A.D., Chodick G., Karpati T., Kamer L., Kremer E., Green M.S., et al. Diabetes as a risk factor for herpes zoster infection: results of a population-based study in Israel. Infection 2008 Jun, 36(3):226-230.
14. 1995 census of population and housing 1998, Israel Central Bureau of Statistics, Jerusalem.
15. Chodick G., Heymann A.D., Shalev V., Kookia E. The epidemiology of diabetes in a large Israeli HMO. Eur J Epidemiol 2003, 18(12):1143-1146.
16. Insinga R.P., Itzler R.F., Pellissier J.M., Saddier P., Nikas A.A. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med 2005 Aug, 20(8):748-753.
17. Thomas S.L., Hall A.J. What does epidemiology tell us about risk factors for herpes zoster?. Lancet Infect Dis 2004 Jan, 4(1):26-33.
18. Donahue J.G., Choo P.W., Manson J.E., Platt R. The incidence of herpes zoster. Arch Intern Med 1995 Aug 7-21, 155(15):1605-1609.
19. Pierik J.G., Gumbs P.D., Fortanier S.A., Van Steenwijk P.C., Postma M.J. Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands. BMC Infect Dis 2012 May 10, 12(1):110.
20. Jih J.S., Chen Y.J., Lin M.W., Chen Y.C., Chen T.J., Huang Y.L., et al. Epidemiological features and costs of herpes zoster in Taiwan: a national study 2000 to 2006. Acta Derm Venereol 2009 Nov, 89(6):612-616.
21. Leung J., Harpaz R., Molinari N.A., Jumaan A., Zhou F. Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination. Clin Infect Dis 2011 Feb 1, 52(3):332-340.
22. Pinchinat S., C-C A., Bricout H., Johnson R.W. Similar herpes zoster incidence across Europe: results from a systematic literature review. BMC Infect Dis 2013, 13(1):170.
23. Hata A., Kuniyoshi M., Ohkusa Y. Risk of herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study. Infection 2011 Dec, 39(6):537-544.
24. Gnann J.W., Whitley R.J. Clinical practice. Herpes zoster. N Engl J Med 2002 Aug 1, 347(5):340-346.
25. Borba E.F., Ribeiro A.C., Martin P., Costa L.P., Guedes L.K., Bonfa E. Incidence, risk factors, and outcome of herpes zoster in systemic lupus erythematosus. J Clin Rheumatol 2010 Apr, 16(3):119-122.
26. Gebo K.A., Kalyani R., Moore R.D., Polydefkis M.J. The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy era. J Acquir Immune Defic Syndr 2005 Oct 1, 40(2):169-174.
27. Health in Israel - selected data 2010, Israeli Ministry of Health, Jerusalem.
28. Jung B.F., Johnson R.W., Griffin D.R., Dworkin R.H. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 2004 May 11, 62(9):1545-1551.
29. Yih W.K., Brooks D.R., Lett S.M., Jumaan A.O., Zhang Z., Clements K.M., et al. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003. BMC Public Health 2005, 5:68.
30. Chao D.Y., Chien Y.Z., Yeh Y.P., Hsu P.S., Lian I.B. The incidence of varicella and herpes zoster in Taiwan during a period of increasing varicella vaccine coverage, 2000-2008. Epidemiol Infect 2011 Sep 12, 1-10.
31. Glesby M.J., Hoover D.R., Tan T., Shi Q., Gao W., French A.L., et al. Herpes zoster in women with and at risk for HIV: data from the Women's Interagency HIV Study. J Acquir Immune Defic Syndr 2004 Dec 15, 37(5):1604-1609.
32. Geerlings S.E., Hoepelman A.I. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 1999 Dec, 26(3-4):259-265.
33. Schmader K., George L.K., Burchett B.M., Hamilton J.D., Pieper C.F. Race and stress in the incidence of herpes zoster in older adults. J Am Geriatr Soc 1998 Aug, 46(8):973-977.
34. Russell M.L., Schopflocher D.P., Svenson L.W. Health disparities in chickenpox or shingles in Alberta?. Can J Public Health 2008 Jan-Feb, 99(1):41-45.